Top Abstract Purchase Related
Home
>
Node
>
Subnode

Antiviral preparations in the therapy of chronic viral hepatitis

Geller, L.I.

Terapevticheskii Arkhiv 62(11): 15-19

1990

ISSN/ISBN: 0040-3660
PMID: 1710074
Document Number: 349475
The author analyzes current data on the potentialities of antiviral therapy of patients suffering from chronic viral hepatitides. Provides the data on the short- and long-term therapeutic effects of interferon drugs and other antiviral agents, describes side effects produced by such type drugs. Compares the clinico-enzymatic, pathohistologic characteristics of the liver status with the degree of elimination of serum antigenic markers of virus B hepatitis in patients afflicted with chronic viral hepatitides. Relates the effects of antiviral drugs in patients suffering from chronic virus non-A non-B hepatitis.

Document emailed within 1 workday
Secure & encrypted payments

Ono, S.K.; da Silva, L.C.; Carrilho, F.J.; da Fonseca, L.E.; Mendes, L.C.; Madruga, C.L.; Farias, A.d.Q.; Laudanna, A.A. 1996: Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy Revista do Hospital das Clinicas 51(5): 180-183
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Lopukhova, N.L. 2007: Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 146-152
Zhdanov, K.V.; Gusev, D.A.; Kozlov, K.V.; Shishkin, M.K.; Sukachev, V.S.; Shakhmanov, D.M.; Zhabrov, S.S. 2015: Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C Voenno-Meditsinskii Zhurnal 336(4): 44-49
Selivestrova, T.R.; Trufanova, I.M.; Morozov, S.V.; Isakov, V.A. 2011: Indicators of body composition as prognostic factors of efficiency of antiviral therapy for chronic hepatitis C Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Baranova, I.P.; Zykova, O.A.; Krasnova, L.I.; Romantsov, M.G.; Nikol'skaia, M.V.; Aftaeva, L.N. 2013: Efficiency of remaxol in preventing unwanted side effects of the antiviral therapy in patients with chronic hepatitis C Eksperimental'naia i Klinicheskaia Farmakologiia 76(11): 44-46
Xu, D.-Z.; Xie, Y.; Li, Z.-Q. 2005: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 550-553
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Dong, Y.; Zhang, H.-f.; Chen, H.; Li, J.; Yang, X.-j.; Zhu, S.-s.; Cheng, Y. 2008: Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(5): 364-366
Vukobrat-Bijedić, Z.; Lacević, N.; Husić-Selimović, A.; Prohić, D. 2003: Therapy of chronic viral hepatitis B Medicinski Arhiv 57(1 Suppl 2: 95-97
Kuroki, T. 1992: Therapy with interleukin 2 for chronic viral hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1984-1989
Rizzetto, M. 1999: Therapy of chronic viral hepatitis: a critical view Italian Journal of Gastroenterology and Hepatology 31(8): 781-793
Gwak, G-Youn.; Kim, T.Hun.; Yu, S.Jong.; Yoon, J-Hwan.; Yong, J.Jung.; Park, S.Cheol.; Lee, H-Suk. 2007: Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients Hepato-Gastroenterology 54(75): 844-848
Pár, A. 1992: Pathogenesis, therapy, prevention and prognosis in chronic viral hepatitis Orvosi Hetilap 133 Suppl. 1: 51-63
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889
Cooper, C.L.; Mills, E.; Wabwire, B.O.; Ford, N.; Olupot-Olupot, P. 2008: Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 13(3): 302-306
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14